I. Introduction
Breast cancer is estimated to have caused approximately 28,000 deaths in Canadian women in 2022 [1]. The timely intervention has shown to be effective in reducing the fatality rate, from 73% for a stage 4 diagnosis to only 1% for a stage 1 diagnosis. Microwave radar technology (MWR) offers safe, compact, wearable, and cost-efficient solutions while bypassing the downsides of ionizing radiation and discomfort of mammography, and high cost and limited accessibility of magnetic resonance imaging (MRI) [2].